malondialdehyde has been researched along with Coronary Artery Disease in 108 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.85) | 18.7374 |
| 1990's | 4 (3.70) | 18.2507 |
| 2000's | 39 (36.11) | 29.6817 |
| 2010's | 53 (49.07) | 24.3611 |
| 2020's | 10 (9.26) | 2.80 |
| Authors | Studies |
|---|---|
| Kawasaki, T | 1 |
| Aslanabadi, N; Khaki-Khatibi, F; Mehri, H; Nourazarian, A; Shademan, B | 1 |
| Anderson, DR; Chen, SC; Duryee, MJ; Lomzenski, HE; Mikuls, TR; Ormseth, MJ; Thiele, GM; Ye, F | 1 |
| Abdollahpour-Alitappeh, M; Ahmadi, R; Azadegan-Dehkordi, F; Bagheri, N; Kazemian, S; Khaledifar, A; Rafiei, A | 1 |
| Ayyamkulamkara, SS; Perumal, SM; Varadhan, S; Venkatachalam, R | 1 |
| Abe, S; Hashimoto, R; Hasumi, H; Hirose, S; Inoue, T; Masuyama, T; Numao, T; Sakuma, M; Toyoda, S; Waku, R; Yazawa, H | 1 |
| Abolhasani, S; Khanbabaei, N; Mahmoodi, N; Saadati, HM; Shahbazloo, SV | 1 |
| Alexopoulos, D; Andreadou, I; Dimitriadis, G; Ikonomidis, I; Katogiannis, K; Katsimaglis, G; Kousathana, F; Kyriakou, E; Lambadiari, V; Maratou, E; Papadopoulou, A; Parissis, J; Plotas, P; Stamatelopoulos, K; Taichert, M; Tsantes, AE; Tsoumani, M; Varlamos, C | 1 |
| Fujita, H; Ito, T; Ohte, N; Seo, Y; Sugiura, T; Yokoi, M | 1 |
| Abbaszadeh-Goudarzi, K; Azimi, H; Ilchi, N; Mosallanejad, S; Nadimi Shahraki, Z; Pourghadamyari, H; Rohani Borj, M; Sahebkar, A | 1 |
| Ekin, S; Sahinalp, S; Yildiz, D | 1 |
| Hiraya, D; Hoshi, T; Ieda, M; Sakai, S; Sato, A; Watabe, H | 1 |
| Hamzan, NS; Ibrahim, ZO; Mokhsin, A; Nawawi, H; Rahman, T; Rahmat, R; Razali, R; Thevarajah, M | 1 |
| Ayers, C; Clopton, P; de Lemos, JA; Khera, A; Prasad, A; Tsimikas, S; Witztum, JL | 1 |
| Jiang, H; Lin, Y; Liu, J; Wan, J; Wang, M; Wang, Z; Xu, Y; Ye, J | 1 |
| Abdul Shukor, MF; Dimon, MZ; Ismail, NAS; M Nor, IF; Mohd Ali, R; Mohd Ghazi, A; Musthafa, QA; Wan Ngah, WZ | 1 |
| Dastani, M; Kazerani, HR; Razani, Z | 1 |
| Altın, C; Müderrisoğlu, H; Özyıldız, A; Yılmaz, M | 1 |
| Borges, JP; Coelho, MP; Kopiler, DA; Lopes, GO; Matsuura, C; Medeiros-Lima, DJM; Mediano, MFF; Nascimento, AR; Nascimento, PMC; Tibirica, E | 1 |
| Batbout, F; Gamra, H; Hadj Ahmed, S; Hammami, M; Hininger-Favier, I; Kaoubaa, N; Kharroubi, W; Lizard, G; Najjar, MF; Zarrouk, A | 1 |
| Gong, D; Sun, H; Wang, F; Zhang, L; Zhang, Y; Zhou, X | 1 |
| Akkerhuis, KM; Boersma, E; Caga-Anan, M; de Jaegere, P; Fedorowski, A; Hartley, A; Haskard, DO; Kardys, I; Khamis, RY; Ligthart, JMR; Melander, O; Oemrawsingh, RM; Regar, E; Serruys, PW; Umans, VAWM; van den Berg, VJ; van Geuns, RJ; van Mieghem, N | 1 |
| Ai, Y; Dong, H; Wang, J; Xu, L; Zhang, Q | 1 |
| Garg, M; Itsiopoulos, C; Kucianski, T; Mayr, HL; Radcliffe, J; Thomas, CJ; Tierney, AC; Willcox, J | 1 |
| Ergüder, İ; Ermiş, E; Karakurt Arıtürk, Ö; Sarı, M; Üreten, K; Yazıhan, N | 1 |
| Chithra, V; Dinesh, RD; Simon, AS; Vijayakumar, T; Vijayan, A | 1 |
| Lai, J; Shang, Y; Sun, J; Wu, B; Zhu, J | 1 |
| Beyan, C | 1 |
| Karakurt Arıtürk, Ö | 1 |
| Caglar, FN; Caglar, IM; Ciftci, S; Dasli, T; Demir, B; Gedikbasi, A; Karakaya, O; Ugurlucan, M; Ungan, I; Vural, A | 1 |
| Honma, H; Kajiwara, T; Matsui, M; Nagasawa, K; Nakagawa, R; Oda, T; Ono, M; Sasai, T; Satoh, J; Takahashi, K; Takahashi, Y; Takebe, N; Taneichi, H | 1 |
| Ahmadi, Y; Badalzadeh, R; Faghfoori, Z; Ghavimi, H; Jabbarpour, M; Karami, H; Majidinia, M; Samadi, N; Shafiei-Irannejad, V; Yousefi, B | 1 |
| Lee, BJ; Lin, JS; Lin, PT; Lin, YC | 2 |
| Anderson, DR; Bussey, WD; Duryee, MJ; Garvin, RP; Hunter, CD; Klassen, LW; Mikuls, TR; Sayles, HR; Shurmur, SW; Thiele, GM; Um, JY | 1 |
| Akagi, H; Akasaka, T; Imanishi, T; Ino, Y; Kitabata, H; Komukai, K; Kubo, T; Kumiko, H; Matsuo, Y; Okumoto, Y; Orii, M; Ozaki, Y; Shimamura, K; Shiono, Y; Takarada, S; Tanaka, A; Tanimoto, T; Ueno, S; Yamaguchi, T; Yamano, T | 1 |
| Andreadou, I; Gravanis, K; Ikonomidis, I; Lekakis, J; Makavos, G; Papadavid, E; Paraskevaidis, I; Parissis, J; Pavlidis, G; Rigopoulos, D; Theodoropoulos, K; Triantafyllidi, H; Varoudi, M | 1 |
| Amini, M; Azari, A; Esfehanizadeh, J; Ferns, GA; Ghayour-Mobarhan, M; Khojasteh, R; Khorashadizadeh, F; Mirzaee, A; Moodi, F; Moohebati, M; Mottahedi, B; Mousavi, S; Paydar, R; Rahsepar, AA; Sahebkar, A; Tavallaie, S | 1 |
| Bujo, H; Kanno, T; Kotani, K; Maekawa, M; Miyazaki, A; Nakamura, Y; Saito, Y; Tashiro, J; Yamazaki, K | 1 |
| Akbari, A; Dadjou, Y; Panahi, Y; Pishgoo, B; Sahebkar, A | 1 |
| Amrein, K; Binder, J; Cvirn, G; Ferstl, U; Froehlich, H; Hallström, S; Hörl, G; Jürgens, G; Koidl, C; Ledinski, G; Scharnagl, H; Stojakovic, T; Tafeit, E; Trauner, M | 1 |
| Cui, NH; Han, YD; Huang, ZL; Li, C; Liu, ZJ; Wang, XB; Zhang, S; Zheng, F | 1 |
| Čegan, A; Čermák, T; Kanďár, R; Laštovička, P; Líbalová, M; Matějka, J; MuŽáková, V; Novotný, V; Skalický, J | 1 |
| Belik, IV; Denisenko, AD; Ivantsova, AA; Mamedova, ZE | 1 |
| Dohi, Y; Fukuda, Y; Higaki, T; Ikenaga, H; Ishibashi, K; Iwasaki, T; Kihara, Y; Kono, S; Kurisu, S; Mitsuba, N; Shimonaga, T; Sumimoto, Y; Watanabe, N | 1 |
| Anazawa, T; Fuji, T; Furuya, S; Hirayama, A; Iida, K; Kawamata, H; Kumabe, T; Matsumoto, M; Nagao, K; Sato, Y; Takahashi, H; Tani, S | 1 |
| Ikeda, S; Koga, S; Kohno, S; Miyahara, Y; Oka, H | 1 |
| Aarts, LP; Driessen, AH; Gerritsen, WB; Haas, FJ; Morshuis, WJ; van Boven, WJ; van Dongen, EP; Waanders, FG | 1 |
| Azyzova, OA; Dudnik, LB; Pokrovskaya, MA; Savchenkova, AP; Solovyova, NP | 1 |
| Chen, Z; Li, CS; Liu, MB; Wang, JJ | 1 |
| Hu, B; Hui, C; Li, K; Meng, Y; Wang, J; Zhang, C | 1 |
| Gupta, S; Mahajan, V; Sodhi, S | 1 |
| Balogun, WO; Elemile, PO; Eziyi, AK; Fadero, FF; Idogun, ES; Ogunro, PS; Oninla, SO | 1 |
| Chang, YT; Gong, ZX; Ran, K; Xu, JM | 1 |
| Goto, D; Hirata, K; Katoh, C; Manabe, O; Morita, K; Naya, M; Tamaki, N; Tsutsui, H; Yoshinaga, K | 1 |
| Hayashi, S; Taguchi, A | 1 |
| Antoniades, C; Antonopoulos, AS; Bakogiannis, C; Chatzistamatiou, E; Ioakeimidis, N; Liakos, C; Marinou, K; Michaelides, AP; Miliou, A; Soulis, D; Stefanadis, C | 1 |
| Kand'ár, R; Královec, K; Meloun, M; Muzáková, V; Skalický, J; Vojtísek, P; Záková, P | 1 |
| Bakris, G; de Guzman, E; Lazich, I; Oliva, R; Patel, A; Sarafidis, P | 1 |
| Chen, SJ; Huang, YC; Lee, BJ; Lin, PT | 2 |
| Akhmedov, A; Camici, GG; Cosentino, F; Franzeck, FC; Hasun, M; Hof, D; Lüscher, TF; Maier, W; Shi, Y; Spescha, RD; Steffel, J; Tanner, FC; von Eckardstein, A; Wyss, CA | 1 |
| Chen, M; Cheng, L; Ding, H; He, M; Hu, FB; Huang, S; Wang, D; Wu, T; Zhang, X; Zhou, L | 1 |
| Kutala, VK; Naushad, SM; Seshagiri Rao, D; Vijaya Lakshmi, SV | 1 |
| Akagi, H; Akasaka, T; Hirata, K; Imanishi, T; Ino, Y; Ishibashi, K; Kitabata, H; Komukai, K; Kubo, T; Matsuo, Y; Okumoto, Y; Tanimoto, T | 1 |
| Asamiya, Y; Nitta, K; Otsubo, S; Tsuruta, Y; Yajima, A | 1 |
| Hsia, S; Huang, YC; Ko, YW; Lee, BJ; Lin, PT; Lin, YC | 1 |
| Hata, N; Inami, S; Kobayashi, N; Mizuno, K; Murakami, D; Ohba, T; Okamatsu, K; Seino, Y; Tajika, K; Takano, M; Yamamoto, M | 1 |
| Alabarse, PV; Benfato, MS; Gonçalves, SC; Hackenhaar, FS; Klein, C; Martinez, D; Medeiros, TM; Wainstein, MV | 1 |
| Kotamraju, S; Kutala, VK; Lakshmi, SV; Naushad, SM; Rao, DS; Reddy, CA; Saumya, K | 1 |
| Feng, L; Han, X; Hu, S; Jia, X; Song, Y; Wang, R; Zhang, M; Zhang, X; Zhu, M | 1 |
| Hörkkö, S; Kastarinen, H; Kesäniemi, YA; Koivula, MK; Kummu, O; Lehtimäki, J; Risteli, J; Turunen, SP; Veneskoski, M; Wang, C | 1 |
| Falkeborn, M; Lithell, H; Naessén, T; Persson, I; Vessby, B | 1 |
| McDowell, A; Wisdom, GB; Young, IS | 1 |
| Ceglarek, W; Jacheć, W; Skrzep-Poloczek, B; Tomasik, A; Walichiewicz, P; Widenka, K; Wodniecki, J; Wojciechowska, C; Woś, S | 1 |
| Lee, P; Prasad, K | 1 |
| Bannikov, AI; Gurevich, VS; Pleskov, VM; Pleskova, IuV | 1 |
| Ahn, JY; Ahn, TH; Choi, IS; Choi, YM; Han, SH; Kim, DS; Kim, HS; Koh, KK; Shin, EK | 1 |
| Balbi, M; Barsotti, A; Brunelli, C; Fabbi, P; Garibaldi, S; Ghigliotti, G; Odetti, P; Rossettin, P; Spallarossa, P | 1 |
| Cheng, S; Corrocher, R; Friso, S; Girelli, D; Grow, MA; Martinelli, N; Olivieri, O; Pignatti, PF; Pizzolo, F; Stranieri, C; Tenuti, I; Trabetti, E | 1 |
| Brown, WV; Davis, WW; Gradek, WQ; Harris, MT; Le, NA; Yahia, N | 1 |
| Li, GX; Li, P | 1 |
| Mao, JM; Wang, G; Wang, X; Zhang, FC | 1 |
| Daida, H; Kotani, K; Kume, A; Miyazaki, T; Mokuno, H; Ohmura, H; Sato, O; Sato, Y; Shimada, K; Sumiyoshi, K; Watanabe, Y | 1 |
| Jaakkola, O; Jokela, H; Lehtimäki, T; Metso, S; Nikkilä, M; Rontu, R | 1 |
| Bayrak, A; Demirtaş, E; Dursun, P; Yarali, H | 1 |
| Akalin, Z; Bilge, A; Ilhan, E; Mutlu-Türkoğlu, U; Nişanci, Y; Uysal, M; Yilmaz, E | 1 |
| Błaszczyk, J; Cegliński, T; Grycewicz, J; Irzmański, R; Kowalczyk, E; Kowalski, J; Liban-Gałka, B; Pawlicki, L | 1 |
| Alver, A; Kalyoncu, NI; Karahan, SC; Koramaz, I; Ozcan, F; Pulathan, Z; Usta, S; Yaris, E | 1 |
| Das, N; Das, S; Ray, R; Srivastava, LM | 1 |
| Gupta, SK; Joshi, S; Mangi, S; Misra, R; Mittal, S; Pandey, RM | 1 |
| Bogavac-Stanojevic, N; Jelić-Ivanovic, Z; Kalimanovska-Ostric, D; Kotur-Stevuljevic, J; Memon, L; Spasic, S; Spasojevic-Kalimanovska, V; Stefanovic, A; Zunic, G | 1 |
| Berger, PB; Brilakis, ES; Kornman, KS; Lennon, RJ; McConnell, JP; Miller, ER; Tsimikas, S; Witztum, JL | 1 |
| Dogukan, A; Gunal, AL; Poyrazoglu, OK; Seckin, D; Yalniz, M | 1 |
| Hayashi, Y; Imamura, A; Matsui, H; Miura, M; Murakami, R; Murohara, T; Numaguchi, Y; Ogawa, Y; Okumura, K; Takahashi, R | 1 |
| Akkaya, C; Eroz, E; Kirli, S; Ocak, N; Sarandol, A; Sarandol, E | 1 |
| Birkner, E; Błaszczyk, U; Kasperczyk, A; Kasperczyk, S; Zalejska-Fiolka, J | 1 |
| Arnaud, J; Boissonnat, P; de Lorgeril, M; Dureau, G; Favier, A; Guidollet, J; Renaud, S; Richard, MJ | 1 |
| Boer, JM; Kruijssen, DA; Princen, HM; Seidell, JC; Steyger, R; van de Vijver, LP; van Poppel, G | 1 |
| Fischer, HJ; Haas, J; Lotze, U; Madzgalla, I; Pfeifer, R; Schubert, K; Thiele, A; Thiele, R; Winnefeld, K | 1 |
| Aykaç-Toker, G; Babalik, E; Bulur, H; Dogru-Abbasoglu, S; Kanbagli, O; Oztürk, S; Uysal, M | 1 |
| Büyükkoçak, U; Cimen, MY; Durak, I; Kaçmaz, M; Oztürk, HS | 1 |
| Gupta, OP; Jain, AP; Jajoo, UN; Kalantri, SP; Mohan, A; Srivastava, LM | 1 |
| Chari, S; Gupta, M | 1 |
| Khoschsorur, G; Renner, W; Rigler, B; Stanger, O; Wascher, TC | 1 |
| Ersöz, A; Gökgöz, L; Halit, V; Kalaycioglu, S; Oktar, GL; Sinci, V; Soncul, H | 1 |
| Kishko, AS; Moshchich, VP | 1 |
| Weiss, K | 1 |
25 trial(s) available for malondialdehyde and Coronary Artery Disease
| Article | Year |
|---|---|
β-Amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease.
Topics: Aged; Amyloid beta-Peptides; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Malondialdehyde; Middle Aged; Mitochondrial Proteins; Myocardial Revascularization; Platelet Activation; Risk Factors | 2020 |
Cardioprotective Effects of Pomegranate (Punica granatum) Juice in Patients with Ischemic Heart Disease.
Topics: Aged; Angina, Unstable; C-Reactive Protein; Cardiotonic Agents; Coronary Artery Disease; Female; Fruit and Vegetable Juices; Humans; Interleukin-6; Lythraceae; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Polyphenols; Reperfusion Injury; Troponin; Tumor Necrosis Factor-alpha | 2017 |
Ad libitum Mediterranean diet reduces subcutaneous but not visceral fat in patients with coronary heart disease: A randomised controlled pilot study.
Topics: Adiponectin; Australia; Biomarkers; Body Composition; Cohort Studies; Coronary Artery Disease; Diet, Mediterranean; Female; Humans; Intra-Abdominal Fat; Male; Malondialdehyde; Middle Aged; New Zealand; Pilot Projects; Subcutaneous Fat; Treatment Outcome | 2019 |
Long-term isosorbide mononitrate treatment impairs endothelial function in patients with coronary artery disease.
Topics: Administration, Oral; Aged; Biomarkers; Brachial Artery; C-Reactive Protein; China; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Endothelium, Vascular; Female; Humans; Isosorbide Dinitrate; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Superoxide Dismutase; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents | 2013 |
Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Antioxidants; Biomarkers; Body Mass Index; Carnitine; Catalase; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dietary Supplements; Dose-Response Relationship, Drug; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Single-Blind Method; Superoxide Dismutase; Triglycerides | 2014 |
Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Topics: Aged; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Dose-Response Relationship, Drug; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Macrophages; Male; Malondialdehyde; Matrix Metalloproteinase 9; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Pyrroles; Tomography, Optical Coherence | 2014 |
Antiinflammatory effects of L-carnitine supplementation (1000 mg/d) in coronary artery disease patients.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antioxidants; Biomarkers; C-Reactive Protein; Carnitine; Coronary Artery Disease; Cytokines; Dietary Supplements; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2015 |
Antioxidant Activity of Heracleum persicum Fruit Extract: Evidence from a Randomized Controlled Trial.
Topics: Adolescent; Adult; Aged; Antioxidants; Catalase; Coronary Artery Disease; Double-Blind Method; Female; Fruit; Glutathione; Glutathione Peroxidase; Heracleum; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Plant Extracts; Superoxide Dismutase; Young Adult | 2016 |
Impact of Malondialdehyde-Modified Low-Density Lipoprotein on Tissue Characteristics in Patients With Stable Coronary Artery Disease - Integrated Backscatter-Intravascular Ultrasound Study.
Topics: Aged; Coronary Artery Disease; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Retrospective Studies; Ultrasonography, Interventional | 2016 |
Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.
Topics: Aged; Atorvastatin; Blood Platelets; Cholesterol; Combined Modality Therapy; Coronary Artery Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Interleukin-6; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; P-Selectin; Pyrroles; Time Factors; Treatment Outcome; Triglycerides | 2008 |
Myocardial oxidative stress, and cell injury comparing three different techniques for coronary artery bypass grafting.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Artery Disease; Creatine Kinase; Female; Humans; Male; Malondialdehyde; Middle Aged; Myocardium; Oxidative Stress; Prospective Studies; Treatment Outcome; Troponin T | 2008 |
[Study of MDA-LDL by pioglitazone and pitavastatin in patients with type 2 diabetes].
Topics: Aged; Arteriosclerosis; Biomarkers; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Disease Progression; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pioglitazone; Quinolines; Risk Factors; Thiazolidinediones | 2011 |
Exercise duration as a determinant of vascular function and antioxidant balance in patients with coronary artery disease.
Topics: Aged; Antioxidants; Blood Flow Velocity; Coronary Artery Disease; Cross-Over Studies; Elasticity; Exercise; Exercise Therapy; Humans; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Superoxide Dismutase-1; Vascular Resistance; Walking | 2011 |
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study.
Topics: Adiponectin; Adult; Aged; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Isoprostanes; Lipids; Male; Malondialdehyde; Metabolic Syndrome; Middle Aged; Oxidative Stress; Rosiglitazone; Simvastatin; Thiazolidinediones | 2012 |
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antioxidants; Catalase; Coronary Artery Disease; Dietary Supplements; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Postmenopause; Superoxide Dismutase; Ubiquinone | 2012 |
Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; C-Reactive Protein; Coronary Artery Disease; Dietary Supplements; Female; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Male; Malondialdehyde; Patient Dropouts; Superoxide Dismutase; Ubiquinone | 2012 |
Malondialdehyde-modified low-density lipoprotein is a useful marker to identify patients with vulnerable plaque.
Topics: Aged; Angioscopy; Biomarkers; Coronary Artery Disease; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Plaque, Atherosclerotic | 2012 |
Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Topics: Administration, Oral; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Apoprotein(a); Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Fatty Acids; Female; Humans; Lipid Peroxidation; Lipoprotein(a); Malondialdehyde; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Tocopherols; Treatment Outcome; Triglycerides | 2002 |
Vascular effects of step I diet in hypercholesterolemic patients with coronary artery disease.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Inflammation Mediators; Lipoproteins; Male; Malondialdehyde; Middle Aged; Nitrates; Vasodilation; Vasomotor System | 2003 |
Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease.
Topics: Aged; Aged, 80 and over; Autoantibodies; Coconut Oil; Coronary Artery Disease; Diet; Double-Blind Method; Fatty Acids, Monounsaturated; Humans; Immunoglobulin G; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Plant Oils; Rapeseed Oil; Safflower Oil | 2004 |
[Estimation of antioxidative effect of atorvastatin and fluvastatin used in primary prevention of coronary heart disease--effect on lipid peroxidation].
Topics: Adult; Anticholesteremic Agents; Antioxidants; Atorvastatin; Coronary Artery Disease; Fatty Acids, Monounsaturated; Female; Fluvastatin; Free Radical Scavengers; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Primary Prevention; Pyrroles; Treatment Outcome | 2005 |
Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting.
Topics: Acetylcysteine; Coronary Artery Bypass; Coronary Artery Disease; Female; Free Radical Scavengers; Heart Arrest, Induced; Hemodynamics; Humans; Hypothermia, Induced; Male; Malondialdehyde; Middle Aged; Myocardial Ischemia; Reperfusion Injury; Treatment Outcome; Troponin I | 2006 |
LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: a randomized controlled clinical trial.
Topics: Carotenoids; Cholesterol; Coronary Artery Disease; Estrogen Replacement Therapy; Female; Glutathione; Humans; Lipids; Lycopene; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Triglycerides | 2006 |
Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
Topics: Adult; Anticoagulants; Biomarkers; C-Reactive Protein; Combined Modality Therapy; Coronary Artery Disease; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Inflammation Mediators; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Dialysis; Single-Blind Method; Superoxide Dismutase; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Biochemical and hemodynamic effects of ascorbic acid and alpha-tocopherol in coronary artery surgery.
Topics: Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Biomarkers; Cardioplegic Solutions; Cardiopulmonary Bypass; Coronary Artery Disease; Creatine Kinase; Creatine Kinase, MB Form; Female; Humans; Injections, Intravenous; Isoenzymes; Male; Malondialdehyde; Middle Aged; Myocardial Reperfusion Injury | 2001 |
83 other study(ies) available for malondialdehyde and Coronary Artery Disease
| Article | Year |
|---|---|
Prospects for the Combined Evaluation of Circulating Malondialdehyde-Modified Low-Density Lipoprotein Measurement and High-Intensity Plaque on T1-Weighted Cardiac Magnetic Resonance Angiography in the Prediction of Cardiovascular Events.
Topics: Coronary Artery Disease; Humans; Lipoproteins, LDL; Magnetic Resonance Angiography; Malondialdehyde; Plaque, Atherosclerotic | 2021 |
Evaluation of the serum levels of Mannose binding lectin-2, tenascin-C, and total antioxidant capacity in patients with coronary artery disease.
Topics: Aged; Antioxidants; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Male; Malondialdehyde; Mannose-Binding Lectin; Middle Aged; Tenascin | 2021 |
Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis.
Topics: Acetaldehyde; Arthritis, Rheumatoid; Atherosclerosis; Autoantibodies; C-Reactive Protein; Coronary Artery Disease; Humans; Immunoglobulin A; Malondialdehyde; Risk Factors | 2022 |
The Serum Levels of IL-36 in Patients with Coronary Artery Disease and Their Correlation with the Serum Levels of IL-32, IL-6, TNF-α, and Oxidative Stress.
Topics: Antioxidants; Coronary Artery Disease; Cytokines; Humans; Interleukin-6; Interleukins; Malondialdehyde; Oxidative Stress; Tumor Necrosis Factor-alpha | 2022 |
Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients.
Topics: Adult; Aged; Antioxidants; Aryldialkylphosphatase; Biomarkers; Cholesterol; Coronary Artery Disease; Glutathione; Humans; Lipoproteins; Lipoproteins, LDL; Malondialdehyde; Middle Aged; Oxidative Stress; Peroxidase; Reactive Oxygen Species; Triglycerides | 2022 |
Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Cross-Over Studies; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress | 2019 |
Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.
Topics: Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinolysis; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; N-Acetylneuraminic Acid; Oxidative Stress; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Reference Values; Risk Factors; ROC Curve; Vitronectin | 2019 |
Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.
Topics: Aged; Aged, 80 and over; Angina, Stable; Biomarkers; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Japan; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Retrospective Studies | 2020 |
Circulating C1q/TNF-related protein-12 levels are associated with the severity of coronary artery disease.
Topics: Adipokines; Antioxidants; Biomarkers; Case-Control Studies; Complement C1q; Coronary Angiography; Coronary Artery Disease; Female; Humans; Inflammation; Male; Malondialdehyde; Middle Aged; Risk Factors; Severity of Illness Index | 2021 |
Evaluations of Antioxidant Enzyme Activities, Total Sialic Acid and Trace Element Levels in Coronary Artery Bypass Grafting Patients.
Topics: Antioxidants; Coronary Artery Bypass; Coronary Artery Disease; Humans; Malondialdehyde; N-Acetylneuraminic Acid; Oxidative Stress; Superoxide Dismutase; Trace Elements | 2021 |
Additional Effect of Coronary High-Intensity Plaque on T1-Weighted Magnetic Resonance Imaging With Circulating Malondialdehyde-Modified Low-Density Lipoprotein on Cardiac Events.
Topics: Coronary Artery Disease; Humans; Lipoproteins, LDL; Magnetic Resonance Imaging; Malondialdehyde; Percutaneous Coronary Intervention; Plaque, Atherosclerotic | 2021 |
Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.
Topics: Adult; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; E-Selectin; Endothelium, Vascular; F2-Isoprostanes; Family; Fasting; Female; Humans; Hyperlipoproteinemia Type II; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Risk Factors; Triglycerides | 2017 |
Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
Topics: Adolescent; Adult; Aortic Diseases; Apolipoprotein B-100; Asymptomatic Diseases; Atherosclerosis; Autoantibodies; Autoimmunity; Black or African American; Cause of Death; Chi-Square Distribution; Coronary Artery Disease; Female; Health Status Disparities; Hispanic or Latino; Humans; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; Odds Ratio; Prevalence; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Texas; White People; Young Adult | 2017 |
Sestrins increase in patients with coronary artery disease and associate with the severity of coronary stenosis.
Topics: Adult; Aged; Coronary Artery Disease; Coronary Stenosis; Electrocardiography; Female; Heat-Shock Proteins; Humans; Male; Malondialdehyde; Middle Aged; Risk Factors; Superoxide Dismutase; Young Adult | 2017 |
Oxidative status and reduced glutathione levels in premature coronary artery disease and coronary artery disease.
Topics: Adult; Age of Onset; Biomarkers; Case-Control Studies; Coronary Artery Disease; Glutathione; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Protein Carbonylation | 2017 |
Are oxidative stress markers helpful for diagnosing the disease and determining its complexity or extent in patients with stable coronary artery disease?
Topics: Aged; Antioxidants; Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Logistic Models; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; Oxidative Stress; Predictive Value of Tests; Risk Factors; Severity of Illness Index | 2017 |
The impact of exercise frequency upon microvascular endothelium function and oxidative stress among patients with coronary artery disease.
Topics: Aged; Biomarkers; Cardiac Rehabilitation; Catalase; Coronary Artery Disease; Endothelium, Vascular; Exercise Therapy; Exercise Tolerance; Forearm; Humans; Lipid Peroxidation; Lipids; Longitudinal Studies; Male; Malondialdehyde; Microcirculation; Microvessels; Middle Aged; Nitric Oxide; Oxidative Stress; Recovery of Function; Regional Blood Flow; Skin; Time Factors; Treatment Outcome | 2018 |
Correlation of trans fatty acids with the severity of coronary artery disease lesions.
Topics: Adult; Aged; Antioxidants; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oleic Acid; Oleic Acids; Oxidative Stress; Severity of Illness Index; Trans Fatty Acids; Triglycerides | 2018 |
East Asian variant of aldehyde dehydrogenase 2 is related to worse cardioprotective results after coronary artery bypass grafting.
Topics: Aldehyde Dehydrogenase, Mitochondrial; China; Coronary Artery Bypass, Off-Pump; Coronary Artery Disease; DNA; Female; Genotype; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Postoperative Period; Prevalence | 2019 |
IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).
Topics: Aged; Atherosclerosis; Biomarkers; Coronary Artery Disease; Female; Humans; Immunoglobulin M; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Necrosis; Prospective Studies | 2018 |
Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
Topics: Aged; Angina, Stable; Angina, Unstable; Apolipoproteins A; Apolipoproteins B; Biomarkers; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Female; Humans; Lipoprotein(a); Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Risk Factors | 2019 |
Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study.
Topics: Adult; Aryldialkylphosphatase; Blood Platelets; Case-Control Studies; Cholesterol; Coronary Artery Disease; Cross-Sectional Studies; Familial Mediterranean Fever; Female; Humans; Male; Malondialdehyde; Platelet Count; Triglycerides | 2013 |
Altered DNA repair, oxidative stress and antioxidant status in coronary artery disease.
Topics: Antioxidants; Ascorbic Acid; Case-Control Studies; Cells, Cultured; Chromatids; Chromosome Breakage; Chromosomes, Human; Coronary Artery Disease; DNA Repair; Female; Glutathione; Humans; Male; Malondialdehyde; Metaphase; Oxidative Stress; Prognosis | 2013 |
Increased mean platelet volume in patients with familial Mediterranean fever may not be a marker of atherosclerosis risk.
Topics: Aryldialkylphosphatase; Blood Platelets; Coronary Artery Disease; Familial Mediterranean Fever; Female; Humans; Male; Malondialdehyde | 2013 |
Author's reply: To PMID 23531873.
Topics: Aryldialkylphosphatase; Blood Platelets; Coronary Artery Disease; Familial Mediterranean Fever; Female; Humans; Male; Malondialdehyde | 2013 |
Contrast layering: late clearance of contrast dye--a novel angiographic phenomenon of early atherosclerosis.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Contrast Media; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Early Diagnosis; Female; Fibrosis; Humans; Iohexol; Male; Malondialdehyde; Middle Aged; Necrosis; Nitric Oxide; Oxidative Stress; Plaque, Atherosclerotic; Predictive Value of Tests; Turkey; Ultrasonography, Interventional; Vascular Calcification | 2015 |
Association of coronary artery calcification with MDA-LDL-C/LDL-C and urinary 8-isoprostane in Japanese patients with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Calcinosis; Carotid Intima-Media Thickness; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dinoprost; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Malondialdehyde; Middle Aged; Multidetector Computed Tomography; Oxidative Stress; Prevalence; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases.
Topics: Adult; Arginine; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Endothelium, Vascular; Fasting; Humans; Islam; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Peripheral Arterial Disease; Vascular Endothelial Growth Factor A | 2014 |
Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease.
Topics: Acetaldehyde; Aged; Autoantibodies; Biomarkers; Case-Control Studies; Coronary Artery Disease; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Plaque, Atherosclerotic | 2014 |
Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation.
Topics: Adult; Angiography; Biomarkers; Brachial Artery; Carotid Intima-Media Thickness; Case-Control Studies; Coronary Artery Disease; Coronary Circulation; Echocardiography, Doppler; Female; Humans; Inflammation; Interleukin-6; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Predictive Value of Tests; Psoriasis; Pulse Wave Analysis; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Vasodilation; Ventricular Dysfunction, Left | 2015 |
Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients.
Topics: Adult; Aged; Autoantibodies; Biomarkers; Cardiac Output; Cardiac Surgical Procedures; Cardiac Valve Annuloplasty; Coronary Artery Bypass; Coronary Artery Disease; Echocardiography; Female; Heart Valve Diseases; Humans; Immunoglobulin G; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged | 2015 |
Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
Topics: Aged; Biomarkers; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Percutaneous Coronary Intervention; Prognosis | 2015 |
Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.
Topics: Adult; Aged; Aged, 80 and over; Antigen-Antibody Complex; Apolipoproteins B; Cholesterol, LDL; Coronary Artery Disease; Coronary Restenosis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Male; Malondialdehyde; Middle Aged; Peripheral Arterial Disease; Simvastatin | 2016 |
Associations of polymorphisms in TXNIP and gene-environment interactions with the risk of coronary artery disease in a Chinese Han population.
Topics: Asian People; Atherosclerosis; Carrier Proteins; Case-Control Studies; Coronary Artery Disease; Ethnicity; Gene-Environment Interaction; Genes, Dominant; Genetic Association Studies; Genetic Loci; Genetic Predisposition to Disease; Haplotypes; Humans; Malondialdehyde; Models, Genetic; Multifactor Dimensionality Reduction; Polymorphism, Single Nucleotide; Regression Analysis; Risk Factors; RNA, Messenger | 2016 |
Fatty acid profile in erythrocyte membranes and plasma phospholipids affects significantly the extent of inflammatory response to coronary stent implantation.
Topics: Aged; Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Erythrocyte Membrane; Fatty Acids; Fatty Acids, Unsaturated; Female; Humans; Inflammation; Male; Malondialdehyde; Oxidative Stress; Percutaneous Coronary Intervention; Phospholipids; Postoperative Complications; Stents | 2016 |
[Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis].
Topics: Acetic Anhydrides; Adult; Aged; Antibodies; Atherosclerosis; Case-Control Studies; Coronary Artery Disease; Female; Humans; Hypochlorous Acid; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Protein Processing, Post-Translational | 2016 |
Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: implication of acute coronary events.
Topics: Acute Coronary Syndrome; Aged; Aorta; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Sinus; Coronary Vasospasm; Female; Humans; Incidence; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Middle Aged; Risk Factors; Ultrasonography, Interventional | 2009 |
Primary biliary cirrhosis and coronary atherosclerosis: protective antioxidant effect of bilirubin.
Topics: Adult; Aged; Antioxidants; Bilirubin; Coronary Artery Disease; Humans; Lipid Peroxidation; Liver Cirrhosis, Biliary; Malondialdehyde; Middle Aged | 2008 |
[A comparison of influence of homocysteine on peroxidase metabolism between elderly patients with or without coronary artery disease].
Topics: Case-Control Studies; Coronary Artery Disease; Female; Homocysteine; Humans; Lipids; Male; Malondialdehyde; Peroxidases; Superoxide Dismutase | 2008 |
The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis.
Topics: Adult; Antigen-Antibody Complex; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Linear Models; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Rheumatoid Factor | 2009 |
Correlation of antioxidants with lipid peroxidation and lipid profile in patients suffering from coronary artery disease.
Topics: Antioxidants; Biomarkers; Case-Control Studies; Catalase; Cholesterol, LDL; Coronary Artery Disease; Humans; Lipid Peroxidation; Lipids; Malondialdehyde; Risk Factors; Superoxide Dismutase; Triglycerides; Vitamin E | 2009 |
Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.
Topics: Antioxidants; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Free Radicals; Humans; Hypertension; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nigeria; Risk Factors; Statistics as Topic; Triglycerides | 2009 |
[Effect of morphine postconditioning on myocardial ischemia-reperfusion injury in rabbits].
Topics: Animals; Coronary Artery Disease; Ischemic Preconditioning, Myocardial; Male; Malondialdehyde; Morphine; Rabbits; Random Allocation; Reperfusion Injury; Superoxide Dismutase | 2009 |
Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers.
Topics: Adult; Aged; Aging; Case-Control Studies; Coronary Artery Disease; Coronary Vessels; Endothelium, Vascular; Hemodynamics; Humans; Ice; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Regional Blood Flow; Smoking; Smoking Cessation; Time Factors; Vasomotor System; Young Adult | 2011 |
Inverse correlation between plasma Beta-carotene and interleukin-6 in patients with advanced coronary artery disease.
Topics: Aged; alpha-Tocopherol; beta Carotene; C-Reactive Protein; Cholesterol; Coronary Artery Disease; Female; Humans; Interleukin-6; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Surveys and Questionnaires | 2010 |
Expression of the aging gene p66Shc is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease.
Topics: Acute Coronary Syndrome; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Monocytes; Oxidative Stress; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Switzerland; Up-Regulation | 2012 |
Short (GT) ( n ) repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress.
Topics: Aged; Coronary Artery Disease; Female; Gene Frequency; Genotype; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Male; Malondialdehyde; Middle Aged; Odds Ratio; Oxidative Stress; Polymorphism, Genetic; Promoter Regions, Genetic; Risk Factors; Tandem Repeat Sequences | 2012 |
Oxidative stress is associated with genetic polymorphisms in one-carbon metabolism in coronary artery disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Carbon; Coronary Artery Disease; Deoxyguanosine; Female; Glutathione; Humans; Male; Malondialdehyde; Oxidative Stress; Polymorphism, Genetic; Protein Carbonylation | 2013 |
Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
Topics: Acute Coronary Syndrome; Aged; Algorithms; Angina Pectoris; Biomarkers; Coronary Artery Disease; Feasibility Studies; Female; Humans; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Odds Ratio; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Risk Factors; Sensitivity and Specificity; Tomography, Optical Coherence | 2013 |
Oxidised LDL/LDL-cholesterol ratio and coronary artery calcification in haemodialysis patients.
Topics: Aged; Algorithms; Cholesterol, LDL; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Japan; Lipoproteins, LDL; Logistic Models; Male; Malondialdehyde; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Severity of Illness Index; Vascular Calcification | 2013 |
The relationship between coenzyme Q10, oxidative stress, and antioxidant enzymes activities and coronary artery disease.
Topics: Adult; Aged; Antioxidants; Catalase; Constriction, Pathologic; Coronary Artery Disease; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Risk; Superoxide Dismutase; Ubiquinone | 2012 |
Oxidized-LDL and paraoxonase-1 as biomarkers of coronary artery disease in patients with sleep-disordered breathing.
Topics: Aryldialkylphosphatase; Biomarkers; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Nitrates; Nitrites; Sleep Apnea Syndromes | 2012 |
Oxidative stress in coronary artery disease: epigenetic perspective.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line; Coronary Artery Disease; Decitabine; DNA Methylation; Endothelial Cells; Epigenesis, Genetic; Female; Ferredoxin-NADP Reductase; Folic Acid; Glutathione S-Transferase pi; Glycine Hydroxymethyltransferase; Homocysteine; Humans; Hydroxamic Acids; Male; Malondialdehyde; Membrane Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidative Stress; Promoter Regions, Genetic; Protein Carbonylation; Proto-Oncogene Proteins; Superoxide Dismutase; Young Adult | 2013 |
Liquiritin attenuates advanced glycation end products-induced endothelial dysfunction via RAGE/NF-κB pathway in human umbilical vein endothelial cells.
Topics: Antibodies, Monoclonal; Apoptosis; Coronary Artery Disease; Down-Regulation; Flavanones; Glucosides; Glycation End Products, Advanced; Herbal Medicine; Human Umbilical Vein Endothelial Cells; Humans; Malondialdehyde; NF-kappa B; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Signal Transduction; Superoxide Dismutase; Transforming Growth Factor beta1 | 2013 |
Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation.
Topics: Animals; Atherosclerosis; Autoantibodies; Coronary Artery Disease; Humans; Immunoglobulin G; Lipoproteins, LDL; Malondialdehyde; Mice; Receptors, LDL | 2013 |
Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
Topics: Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Autoantibodies; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Triglycerides | 2002 |
Lipid peroxidation and vitamin E in human coronary atherosclerotic lesions.
Topics: Antioxidants; Cholesterol; Coronary Artery Disease; Endarterectomy; Humans; Lipid Peroxidation; Malondialdehyde; Oxidants; Statistics as Topic; Vitamin E | 2003 |
Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin.
Topics: Animals; Aorta; Aspirin; Cholesterol; Cholesterol, Dietary; Coronary Artery Disease; Cyclooxygenase Inhibitors; Depression, Chemical; Female; Hypercholesterolemia; Leukocytes; Luminescent Measurements; Malondialdehyde; Oxidative Stress; Rabbits; Time Factors; Triglycerides | 2003 |
[Influenza viruses and atherosclerosis: the role of atherosclerotic plaques in prolonging the persistent form of influenza infection].
Topics: Aged; Animals; Arteriosclerosis; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Humans; Influenza A virus; Influenza, Human; Lipid Peroxidation; Lung; Malondialdehyde; Mice; Middle Aged; Myocardial Ischemia; Polymerase Chain Reaction; RNA, Viral; Spectrophotometry; Thiobarbiturates; Time Factors; Tropism | 2003 |
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities.
Topics: Age of Onset; Aged; Angina, Unstable; Coronary Artery Disease; Humans; Lipid Peroxidation; Malondialdehyde; Metabolic Diseases; Middle Aged; Oxidative Stress | 2004 |
Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction.
Topics: Aryldialkylphosphatase; Coronary Artery Disease; Female; Genotype; Humans; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Oxidative Stress; Polymorphism, Genetic; Risk Factors; Smoking | 2004 |
[Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
Topics: Antioxidants; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Female; Glutathione; Humans; Lipid Peroxides; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction | 2004 |
Effect of homocysteine on plaque formation and oxidative stress in patients with acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Chemokine CCL2; Coronary Artery Disease; Coronary Disease; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Superoxide Dismutase | 2004 |
Circulating malondialdehyde-modified LDL and atherogenic lipoprotein profiles measured by nuclear magnetic resonance spectroscopy in patients with coronary artery disease.
Topics: Aged; Brachial Artery; Coronary Artery Disease; Endothelium, Vascular; Humans; Lipoproteins, LDL; Magnetic Resonance Spectroscopy; Male; Malondialdehyde; Middle Aged; Triglycerides; Vasodilation | 2005 |
Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis.
Topics: Antibodies; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Humans; Malondialdehyde; Predictive Value of Tests; ROC Curve | 2005 |
Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?
Topics: Adult; Aryldialkylphosphatase; Blood Glucose; Cholesterol, HDL; Coronary Artery Disease; Female; Glucose Tolerance Test; Humans; Malondialdehyde; Polycystic Ovary Syndrome; Risk Factors | 2006 |
Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease.
Topics: Adult; Aged; Blood Proteins; Coronary Angiography; Coronary Artery Disease; DNA Damage; Female; Humans; Lymphocytes; Male; Malondialdehyde; Middle Aged; Protein Carbonylation; Reference Values | 2005 |
Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis.
Topics: Animals; Antioxidants; Aorta; Ascorbic Acid; Carotid Stenosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diet, Atherogenic; Hypercholesterolemia; Lipid Peroxidation; Malondialdehyde; Rabbits | 2006 |
Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients.
Topics: Aged; Biomarkers; Coronary Artery Disease; Female; Humans; Inflammation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Singlet Oxygen; Superoxide Dismutase | 2007 |
Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
Topics: Adult; Aged; Apolipoproteins B; Autoantibodies; Biomarkers; Cardiovascular Diseases; Copper; Coronary Artery Disease; Coronary Stenosis; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin M; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Odds Ratio; Risk | 2007 |
Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Carotid Artery, Common; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; Particle Size; Tunica Intima; Ultrasonography | 2007 |
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Aryldialkylphosphatase; C-Reactive Protein; Carboxylic Ester Hydrolases; Coronary Artery Disease; Female; Humans; Leptin; Lipoproteins; Male; Malondialdehyde; Oxidation-Reduction; Risk Factors; Schizophrenia; Triglycerides; Tumor Necrosis Factor-alpha | 2007 |
Effect of garlic supplementation on erythrocytes antioxidant parameters, lipid peroxidation, and atherosclerotic plaque formation process in oxidized oil-fed rabbits.
Topics: Animals; Antioxidants; Brassica rapa; Coronary Artery Disease; Erythrocytes; Fatty Acids, Monounsaturated; Garlic; Glutathione Peroxidase; Lipid Peroxidation; Male; Malondialdehyde; Oxidation-Reduction; Plant Oils; Rabbits; Rapeseed Oil; Superoxide Dismutase | 2007 |
Lipid peroxides and antioxidant defenses in accelerated transplantation-associated coronary arteriosclerosis.
Topics: Adult; Aged; Antioxidants; Coronary Artery Disease; Coronary Disease; Heart Transplantation; Humans; Lipid Peroxides; Malondialdehyde; Middle Aged; Postoperative Complications; Trace Elements | 1993 |
Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.
Topics: Adult; Aged; Autoantibodies; Body Mass Index; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Random Allocation; Regression Analysis; Risk Factors | 1996 |
[Coronary angiography and change in antioxidative status].
Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Prospective Studies; Selenium; Superoxide Dismutase | 1999 |
Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis.
Topics: Adult; Aged; Antioxidants; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Angiography; Coronary Artery Disease; Disease Progression; Glutathione Peroxidase; Humans; Lipid Peroxides; Malondialdehyde; Middle Aged; Reference Values; Selenium; Sulfhydryl Compounds | 1999 |
Blood oxidant/antioxidant status of atherosclerotic patients.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Coronary Artery Disease; Disease Progression; Erythrocytes; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidants; Oxidative Stress | 2001 |
Role of oxygen free radicals in causing endothelial damage in acute myocardial infarction.
Topics: Adult; Aged; Coronary Artery Disease; Endothelium, Vascular; Female; Free Radicals; Humans; India; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Nitrites; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase | 2000 |
Lipid peroxidation and antioxidant enzymes in coronary and peripheral artery disease.
Topics: Adult; Aged; Arteriosclerosis; Coronary Artery Disease; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Reference Values; Superoxide Dismutase | 2001 |
NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease.
Topics: Adult; Age of Onset; Angina Pectoris; Angiography; Coronary Artery Disease; Genotype; Humans; Lipid Peroxidation; Male; Malondialdehyde; Membrane Transport Proteins; Middle Aged; Myocardial Infarction; NAD; NADH, NADPH Oxidoreductases; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Factors | 2001 |
[Pathogenetic mechanisms of atherogenesis in patients with rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Coronary Artery Disease; Heparin; Histamine; Humans; Lipid Peroxidation; Lipids; Malondialdehyde; Myocardial Infarction; Serotonin | 1989 |
[Calcium antagonists: anti-atherosclerotic effect by modification of the prostaglandin system].
Topics: Adult; Aged; Animals; Calcium Channel Blockers; Coronary Artery Disease; Epoprostenol; Female; Humans; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Prostaglandins; Rats; Rats, Inbred Strains; Thromboxane B2 | 1988 |